PharmaVOICE - 
Nov./Dec. 2016
Purchase Issue

In Every Issue
Letter from the Editor
On Tap for 2017 As this issue was going to [...]
By

Taren Grom, Editor

Upfront
Industry at Large AbbVie Ireland Takes Efforts to Reduce Carbon [...]
By

PharmaVOICE Staff

mHealth
Remote Patient Monitoring Device Market to Reach .5 Billion by [...]
By

PharmaVOICE Staff

What’s New
FDA Issues Guidance on Registering Clinical Trials  Trending now: A [...]
By

PharmaVOICE Staff

Pharma Trax
CROs are Leading Drive to Improve the Efficiency of Clinical [...]
By

PharmaVOICE Staff

Tools of the Trade
Deloitte Launches ExaLink, a Multi-Services Platform for Commercial Operations Trending [...]
By

PharmaVOICE Staff

The Calendar
Coming Attractions The Connected Health Conference, Dec. 11-14, at the [...]
By

PharmaVOICE Staff

Talent Pool
Pharma pool Dr. Marielle Cohard-Radice Daiichi Sankyo Announces Global Head [...]
By

PharmaVOICE Staff

On The Cover

Trending 2017: The Cancer Moonshot
Launched in January 2016, the White House’s Cancer Moonshot is a billion initiative to jump-start the effort to eliminate cancer. A large part of this initiative is the development of cancer immunotherapies. In October 2016, Vice President Joe Biden delivered the Cancer Moonshot report that lays out the strategic plan for transforming cancer research [...]
By

PharmaVOICE Staff

Features

Trending 2017: Combination Products
Combination products are products that combine two or more different types of FDA-regulated products, including drugs, biologics, and medical devices. Regulators are working to make this process easier with the establishment of the Combination Product Council, identifying process improvements, and facilitating communication between agency centers. Combination therapies are a natural outgrowth to the evolution of [...]
By

PharmaVOICE Staff

Trending 2017: Gene Editing
The development of human therapeutics using gene editing technologies is an area of major interest that has recently received large public and private investments. The initial applications of gene editing technologies have largely focused on the treatment of monogenic disorders, but other areas, such as immuno-oncology, have also witnessed recently a growing interest from the [...]
By

PharmaVOICE Staff

Trending 2017: Health Bots
Over the past several years, technological innovations in the healthcare industry have come and gone, but only a handful of trends have matured and achieved widespread adoption among healthcare organizations, according to experts at TechTarget, who add that bots are another new development that is piquing the interest of healthcare organizations and attempting to become [...]
By

PharmaVOICE Staff

Trending 2017: Industrial Internet
The Industrial Internet, a term coined by GE, is the integration of complex physical machinery with networked sensors and software. The next state of the Industrial Internet will enable artificial intelligence to make meaningful use of device-collected data. This near future state is generating excitement and receiving massive investments. According to a McKinsey report on [...]
By

PharmaVOICE Staff

Trending 2017: Precision Medicine
Precision medicine holds great promise for improving patient health outcomes. By identifying genetic causes of diseases, doctors can focus on disease prevention, earlier diagnosis when treatments may be more effective, and avoid giving treatments to patients that may cause adverse reactions or that will fail to work. We are just at the beginning of the [...]
By

PharmaVOICE Staff

Trending 2017: Smart Technology
The ability to capture health information in real time is changing the face of healthcare and clinical trials. Take for example Novartis and Qualcomm’s next-generation inhaler that enables patients to have access to their own data on the use of their inhaler in near real time. The small, disposable, and low-power module contained within the [...]
By

PharmaVOICE Staff

Trending 2017: Talent War
For most organizations the war for talent isn’t just with their competitors; it’s a battle being waged on a global basis that transcends industries. As global megatrends escalate, companies are reshaping their businesses and innovating to meet new market demands. The challenge is talent innovation is not keeping pace. According to a recent Deloitte study, [...]
By

PharmaVOICE Staff

Trending 2017: Triple Aim
There is a continuing push within the healthcare ecosystem toward patient-centric care, population health, and cost and value. These three areas dramatically impact the industry across myriad operational and executional channels. Triple Aim, an initiative that serves as the foundation for organizations to successfully navigate the transition from a focus on healthcare to optimizing health, [...]
By

PharmaVOICE Staff

Trending 2017: Virtual Reality
What do Pokemon Go, Zombies, Run!, and Excedrin have in common? They are all using augmented or virtual reality to motivate consumers to be more active, or in the case of Excedrin, to be more compassionate. Earlier this year, Excedrin launched the world’s first augmented reality (AR) migraine simulator, with the aim to provide a [...]
By

PharmaVOICE Staff

SHOWCASE FEATURE: eSolutions
E-Solutions are forever changing the industry. Many of the top 10 trends identified in this issue that are expected to impact the industry in the near- and long-term are based on disruptive technologies and solutions. As Bertalan Mesko, Ph.D., “The Medical Futurist” notes, disruptive technology is already in development for many problems in healthcare. With [...]
By

Taren Grom, Editor

It’s All Related: Veganism, EHR, and Conversational Marketing
Humans have no need for animal products; the increasing numbers of vegans in this country (and planet), is a testament to how easy it is to live a healthily fulfilling lifestyle without ever harming an animal.” This quote by author Angel Finn inspired me to make a change, one my family and I have been [...]
By

Angelo Campano, Director, Customer Experience (EHR & CRM), Ogilvy CommonHealth Worldwide

If A Picture Is Worth A Thousand Words, Video is Worth A Million
At the heart of every digital trend is a user behavior — video is no different. As humans, we have loved telling stories since the beginning of time. We love telling stories, and hearing them, and there is no better medium for storytelling than video. Proof Is in the Numbers: The Data Support This Claim [...]
By

Chris Cullmann, Senior VP, Engagement Strategy, Ogilvy CommonHealth Worldwide

Artificial Intelligence and Visual Analytics: Insight From Biomedical Literature is Now in Sight
The importance of the biomedical literature to the pharmaceutical industry cannot be overstated. Understanding the literature is a cornerstone for discovery, publication planning, competitive intelligence, identification of adverse events, compliance, and more. Despite being so essential for the industry, the methods for discovering critical information from the literature largely remain entrenched in 1950s technology. Even [...]
By

Jeffrey Saffer, President and CEO, Quertle, LLC

Overcoming Dual Reimbursement Challenges With Integrated Digital Solutions
Many of us are watching with fascination and concern as payers decide to exit certain markets in 2017, based on the economics of delivering care in specific states. Meanwhile, there’s another payer trend that is just as important for manufacturers to follow closely — payer formulary adoption of products that require both medical and pharmaceutical [...]
By

Sandy Piscitello, VP, Operations, Triplefin

Data-driven Site Selection Accelerating Your Trials Through Predictive Site Modeling
Accelerated study start-up is the universally acknowledged holy grail of streamlining clinical trial operations. While advancements like central IRB review, adaptive trial designs, and the implementation of electronic systems have led to increased efficiencies across the clinical trial enterprise, the overall start-up phase of a clinical trial continues to be the primary source of trial [...]
By

Suzanne Caruso, VP Clinical Solutions, WIIRB-Copernicus Group

Speak Out
Changing the Drug Development Playbook –MODEL-INFORMED DRUG DEVELOPMENT HAS ARRIVED Imagine that you can reduce the number of patients required for a complex, hard-torecruit clinical trial by ten-fold. Imagine that you can use technology alone to add dosing information for special populations – such as pediatric patients, pregnant women or those with impaired organ function [...]
By

Ellen Leinfuss is senior vice president at Certara

FEEDBACK